CH603626A5 - - Google Patents
Info
- Publication number
- CH603626A5 CH603626A5 CH800275A CH800275A CH603626A5 CH 603626 A5 CH603626 A5 CH 603626A5 CH 800275 A CH800275 A CH 800275A CH 800275 A CH800275 A CH 800275A CH 603626 A5 CH603626 A5 CH 603626A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7511154A FR2306697A1 (fr) | 1975-04-10 | 1975-04-10 | Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH603626A5 true CH603626A5 (OSRAM) | 1978-08-31 |
Family
ID=9153719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH800275A CH603626A5 (OSRAM) | 1975-04-10 | 1975-06-19 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3984411A (OSRAM) |
| JP (1) | JPS51118777A (OSRAM) |
| BE (1) | BE829845A (OSRAM) |
| CA (1) | CA1036597A (OSRAM) |
| CH (1) | CH603626A5 (OSRAM) |
| DE (1) | DE2528360A1 (OSRAM) |
| ES (1) | ES439017A1 (OSRAM) |
| FR (1) | FR2306697A1 (OSRAM) |
| GB (1) | GB1502182A (OSRAM) |
| IT (1) | IT1036400B (OSRAM) |
| LU (1) | LU72743A1 (OSRAM) |
| NL (1) | NL7507441A (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU176972B (hu) * | 1977-06-13 | 1981-06-28 | Gyogyszerkutato Intezet | Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona |
| US4648896A (en) * | 1982-11-15 | 1987-03-10 | Ciba-Geigy Corporation | 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides |
| FI895821A7 (fi) * | 1988-12-07 | 1990-06-08 | The Wellcome Foundation Ltd | Farmaseuttisesti aktivisia CNS-yhdisteitä |
| WO1999024422A1 (en) * | 1997-11-05 | 1999-05-20 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| HRP20050696B1 (en) | 2003-01-14 | 2008-10-31 | Arena Pharmaceuticals Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| ES2316964T3 (es) * | 2003-02-24 | 2009-04-16 | Arena Pharmaceuticals, Inc. | Fenil-y piridilpipereidinia-derivados como moduladores del metabolismo de la glucosa. |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| CA2441775C (en) * | 2003-09-23 | 2004-09-28 | Westport Research Inc. | Container for holding a cryogenic fluid |
| UA92150C2 (ru) * | 2004-06-04 | 2010-10-11 | Арена Фармасьютикалз, Инк. | Замещенные производные арила и гетероарила как модуляторы метаболизма и для профилактики и лечения связанных с ним расстройств |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| ATE429430T1 (de) * | 2005-09-16 | 2009-05-15 | Arena Pharm Inc | Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen |
| TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| ATE500230T1 (de) | 2007-08-30 | 2011-03-15 | Dow Agrosciences Llc | 2-(substituierte phenyl)-6-amino-5-alkoxy-, thioalkoxy- und aminoalkyl-4-pyrimidincarboxylate und ihre verwendung als herbizide |
| SG182610A1 (en) | 2010-01-27 | 2012-08-30 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| MX2013003184A (es) | 2010-09-22 | 2013-06-07 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo. |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| JP6798075B2 (ja) | 2015-06-15 | 2020-12-09 | エヌエムディー ファーマ エー／エス | 神経筋障害を処置するのにおける使用のための化合物 |
| BR112017027656B1 (pt) | 2015-06-22 | 2023-12-05 | Arena Pharmaceuticals, Inc. | Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo |
| CA3053418A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| US10385028B2 (en) | 2017-12-14 | 2019-08-20 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US11591284B2 (en) | 2017-12-14 | 2023-02-28 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US11147788B2 (en) | 2017-12-14 | 2021-10-19 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US11730714B2 (en) | 2017-12-14 | 2023-08-22 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US12440477B2 (en) | 2017-12-14 | 2025-10-14 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| BR112020024762A2 (pt) | 2018-06-06 | 2021-03-23 | Arena Pharmaceuticals, Inc. | métodos de tratamento de condições relacionadas ao receptor s1p1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3259623A (en) * | 1963-06-14 | 1966-07-05 | Olin Mathieson | Process for preparing 2-(secondary amino)-halogenopyrimidines |
| US3261833A (en) * | 1964-10-20 | 1966-07-19 | Smith Kline French Lab | 2,4-diamino-6-aminoalkoxy pyrimidines |
| GB1143167A (en) * | 1967-01-25 | 1969-02-19 | Ucb Sa | Derivatives of pyrimidine |
-
1975
- 1975-04-10 FR FR7511154A patent/FR2306697A1/fr active Granted
- 1975-05-23 GB GB22982/75A patent/GB1502182A/en not_active Expired
- 1975-06-04 BE BE157011A patent/BE829845A/xx not_active IP Right Cessation
- 1975-06-16 LU LU72743A patent/LU72743A1/xx unknown
- 1975-06-19 CH CH800275A patent/CH603626A5/xx not_active IP Right Cessation
- 1975-06-23 NL NL7507441A patent/NL7507441A/xx not_active Application Discontinuation
- 1975-06-25 DE DE19752528360 patent/DE2528360A1/de not_active Withdrawn
- 1975-06-27 CA CA230,309A patent/CA1036597A/fr not_active Expired
- 1975-06-30 JP JP50080752A patent/JPS51118777A/ja active Pending
- 1975-06-30 ES ES439017A patent/ES439017A1/es not_active Expired
- 1975-07-01 IT IT68679/75A patent/IT1036400B/it active
- 1975-07-17 US US05/596,880 patent/US3984411A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3984411A (en) | 1976-10-05 |
| DE2528360A1 (de) | 1976-10-21 |
| LU72743A1 (OSRAM) | 1975-10-08 |
| ES439017A1 (es) | 1977-06-16 |
| JPS51118777A (en) | 1976-10-18 |
| BE829845A (fr) | 1975-12-04 |
| IT1036400B (it) | 1979-10-30 |
| NL7507441A (nl) | 1976-10-12 |
| CA1036597A (fr) | 1978-08-15 |
| GB1502182A (en) | 1978-02-22 |
| FR2306697B1 (OSRAM) | 1979-08-10 |
| FR2306697A1 (fr) | 1976-11-05 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |